Mission
Develop and strengthen Pharmacovigilance through regulatory harmonization activities and proposals that promote the safety and rational use of drugs as a necessary component of public health policies in the Americas.
Objectives
- Promote development and circulation of the knowledge, criteria, and methods used in Pharmacovigilance, which should be used in training and educational activities for all actors related to medicines;
- Analyze and promote development of harmonization tools to support Pharmacovigilance in the Region;
- Develop and promote a network that permits exchange of knowledge, communication, and support for decision-making related to Pharmacovigilance;
- Promote integration of Pharmacovigilance as an essential component of medical programs and public health policies;
- Promote research on Pharmacovigilance and its circulation, as well as analysis of the impact of Pharmacovigilance on public health, emphasizing patient safety.
Members of the Working Group on Pharmacovigilance
Members- MERCOSUR: Salomé Fernández, Uruguay
- COMUNIDAD ANDINA: Claudia Vaca (Coordinador principal), Colombia
- SICA: Indira Credidío, Panama
- CARICOM: Maryam Hinds, Barbados
- NAFTA: Carmen Becerril, Mexico
- ALIFAR: Juan Arriola Colmenares, Peru
- FIFARMA: Ronoldy Valencia, United States
- Designated by PAHO/WHO: Julián Pérez Peña, Cuba
Alternate Members- MERCOSUR: Brazil
- COMUNIDAD ANDINA: Silvia Alvarez, Peru
- SICA: Helbert Saénz, Guatemala
- NAFTA: Heather Sutcliffe
- ALIFAR: Juan Arriola Colmenares, Peru
- FIFARMA: Daniel Ciriano, Argentina
Secretariat (PAHO/WHO)
Conferences and Presentations GT/FV
VII Pan American Conference on Drug Regulatory Harmonization (CPANDRH), 2013- Agenda
- Presentation: Pharmacovigilance in the region of the Americas: Dynamics, Challenges and Perspectives, Verónica Vergara - ANAMED
- Presentation: Regulatory authority and Immunization programs: a joint work for patient safety, David Wood - WHO
- Presentation:Pharmacovigilance: the tool to complete the picture of medicines utilization, Claudia Vaca - MSPPS
VI Pan American Conference on Drug Regulatory Harmonization (CPANDRH), 2011- Presentation: Farmacovigilancia, Dra. Claudia Patricia Vaca (only in Spanish)
V Pan American Conference on Drug Regulatory Harmonization (CPANDRH), 2008Documents of the GT/FV for Public Consultation
- Consulta Señales en Farmacovigilancia (Only in Spanish)
- Consulta sobre Experiencias exitosas (Only in Spanish)
- Consulta Informe periódico de seguridad para las Américas (Only in Spanish)
- Consulta sobre planes de gestión de riesgo (Only in Spanish)
- Consulta de Inspecciones en Farmacovigilancia (Only in Spanish)
Links of note GT/FV
Pharmacovigilance Programs in some Latin American countries- Argentina: Autoridad Reguladora de Referencia Regional para Medicamentos (ANMAT)
- Brasil: Agencia Nacional de Vigilancia Sanitaria (ANVISA)
- Colombia: Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA)
- México: Comisión Federal para la Protección contra Riesgo Sanitario (COFEPRIS)
- United States of America: U.S. Food and Drug Administration (FDA)
- Canada: Health Canada
- El Salvador: Dirección de medicamentos y productos sanitarios
- Guatemala: Servicio de Farmacoviligancia
- Panama: Dirección Nacional de Farmacia y Drogas
- Venezuela: Instituto Nacional de Higiene "Rafael Rangel"
- Ecuador: Sistema Nacional de Farmacovigilancia
- Chile: Departamento Agencia Nacional de Medicamentos (ANAMED)
Technical Documents GT/FV
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
